Insider · CIK 0001715450
Chamath Palihapitiya
Files at AKLI (Akili, Inc.), PROK (PROKIDNEY CORP.). First filing Oct 13, 2023, latest Nov 21, 2023.
In brief
Chamath Palihapitiya files SEC Form 4 as director and 10% owner at PROK (PROKIDNEY CORP.), and also at AKLI (Akili, Inc.). Since Oct 13, 2023, Chamath Palihapitiya has reported 0 open-market buys worth $0 and 10 open-market sells worth $17M, the latest filed on Nov 21, 2023.
A track record needs three past buys with six months of prices behind them; Chamath Palihapitiya has 0, so none is measured yet.
The newest scored trade: sold $9.5M of PROK on Nov 19, 2023, filed Nov 21, 2023, scored 53 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PROK: PROKIDNEY CORP.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | PROKsell PROKIDNEY CORP. | $9.5M 7,256,367 shares | -140% | 0% from low-91% from high | |
| 42Moderate | PROKsell PROKIDNEY CORP. | $988k 752,800 shares | -13% | 0% from low-90% from high | |
| 36Weak | PROKsell PROKIDNEY CORP. | $898k 576,700 shares | -9% | +11% from low-88% from high | |
| 27Weak | PROKsell PROKIDNEY CORP. | $335k 209,833 shares | -3% | +4% from low-89% from high | |
| 33Weak | PROKsell PROKIDNEY CORP. | $688k 405,400 shares | -6% | +11% from low-88% from high | |
| 32Weak | PROKsell PROKIDNEY CORP. | $646k 391,400 shares | -5% | 0% from low-89% from high | |
| 31Weak | PROKsell PROKIDNEY CORP. | $568k 321,473 shares | -4% | +4% from low-87% from high | |
| 36Weak | PROKsell PROKIDNEY CORP. | $900k 447,500 shares | -5% | 0% from low-84% from high | |
| 37Weak | PROKsell PROKIDNEY CORP. | $1.2M 447,043 shares | -5% | +14% from low-79% from high | |
| 37Weak | PROKsell PROKIDNEY CORP. | $1.4M 486,863 shares | -5% | 0% from low-73% from high |
Transactions
Every row this insider has filed, 35 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | AKLI Akili, Inc. | UTender of shares Common Stockindirect: See Footnote | -8,100,000 | - | - | 0 | Jul 5, 2024 |
| Jul 2, 2024 | AKLI Akili, Inc. | UTender of shares Common Stockindirect: See Footnote | -3,773,000 | - | - | 0 | Jul 5, 2024 |
| Jul 2, 2024 | AKLI Akili, Inc. | UTender of shares Common Stockindirect: See Footnote | -1,900,000 | - | - | 0 | Jul 5, 2024 |
| Nov 19, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -5,183,367 | $1.31 | $6.8M | 0 | Nov 21, 2023 |
| Nov 19, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -2,073,000 | $1.31 | $2.7M | 0 | Nov 21, 2023 |
| Nov 15, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -282,300 | $1.49 | $420k | 5,653,867 | Nov 17, 2023 |
| Nov 16, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -212,100 | $1.22 | $259k | 5,441,767 | Nov 17, 2023 |
| Nov 17, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -258,400 | $1.19 | $308k | 5,183,367 | Nov 17, 2023 |
| Nov 9, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -95,900 | $1.68 | $161k | 6,416,967 | Nov 14, 2023 |
| Nov 10, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -85,900 | $1.61 | $138k | 6,331,067 | Nov 14, 2023 |
| Nov 13, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -88,700 | $1.57 | $140k | 6,242,367 | Nov 14, 2023 |
| Nov 14, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -306,200 | $1.50 | $459k | 5,936,167 | Nov 14, 2023 |
| Nov 6, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -79,600 | $1.56 | $124k | 6,643,100 | Nov 8, 2023 |
| Nov 7, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -71,233 | $1.59 | $113k | 6,571,867 | Nov 8, 2023 |
| Nov 8, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -59,000 | $1.66 | $98k | 6,512,867 | Nov 8, 2023 |
| Nov 1, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -123,400 | $1.62 | $200k | 7,004,700 | Nov 3, 2023 |
| Nov 2, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -133,700 | $1.73 | $232k | 6,871,000 | Nov 3, 2023 |
| Nov 3, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -148,300 | $1.73 | $256k | 6,722,700 | Nov 3, 2023 |
| Oct 27, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -92,500 | $1.59 | $147k | 7,427,000 | Oct 31, 2023 |
| Oct 30, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -157,000 | $1.65 | $260k | 7,270,000 | Oct 31, 2023 |
| Oct 31, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -141,900 | $1.69 | $239k | 7,128,100 | Oct 31, 2023 |
| Oct 24, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -176,300 | $1.75 | $309k | 7,664,673 | Oct 26, 2023 |
| Oct 25, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -67,213 | $1.76 | $118k | 7,597,460 | Oct 26, 2023 |
| Oct 26, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -77,960 | $1.80 | $141k | 7,519,500 | Oct 26, 2023 |
| Oct 19, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -200,000 | $2.19 | $439k | 8,088,473 | Oct 23, 2023 |
| Oct 20, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -87,200 | $1.92 | $168k | 8,001,273 | Oct 23, 2023 |
| Oct 23, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -160,300 | $1.83 | $293k | 7,840,973 | Oct 23, 2023 |
| Oct 16, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -215,543 | $2.87 | $619k | 8,519,973 | Oct 18, 2023 |
| Oct 17, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -106,400 | $2.83 | $301k | 8,413,573 | Oct 18, 2023 |
| Oct 18, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -125,100 | $2.28 | $285k | 8,288,473 | Oct 18, 2023 |
| Oct 11, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -75,000 | $3.84 | $288k | 9,147,379 | Oct 13, 2023 |
| Oct 12, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -18,775 | $3.14 | $59k | 9,128,604 | Oct 13, 2023 |
| Oct 12, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -143,088 | $2.63 | $377k | 8,985,516 | Oct 13, 2023 |
| Oct 13, 2023 | PROK PROKIDNEY CORP. | SOpen-market sale Class A ordinary sharesindirect: See footnote | -250,000 | $2.67 | $668k | 8,735,516 | Oct 13, 2023 |
| Nov 2, 2022 | AKLI Akili, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +44,000 | $0.00 | $0 | 44,000 | Nov 4, 2022 |
Questions about Chamath Palihapitiya
Answered from the filings on this page, as of the latest one.
Is Chamath Palihapitiya buying or selling?
Not in the last 12 months. Chamath Palihapitiya's latest open-market trade on SEC Form 4 was sold $9.5M of PROK on Nov 19, 2023.
How did Chamath Palihapitiya's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Chamath Palihapitiya has 0.
Where does Chamath Palihapitiya file Form 4?
Chamath Palihapitiya has filed Form 4 at PROK (PROKIDNEY CORP.); AKLI (Akili, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.